Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tacrolimus In Combination, Tacrolimus Alone Compared (TICTAC Trial): A Prospective Randomized Trial Of Minimized Immunosuppression In Adult Heart Transplant Recipients

NCT00299221 is registered in ClinicalTrials.gov with Newark Beth Israel Medical Center as lead sponsor.

NCT NCT00299221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00299221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tacrolimus In Combination, Tacrolimus Alone Compared (TICTAC Trial): A Prospective Randomized Trial Of Minimized Immunosuppression In Adult Heart Transplant Recipients
Lead sponsor
Newark Beth Israel Medical Center
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2004
Completion date
December 31, 2009
Enrollment
150 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

immunosuppression